• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session

    10/26/22 12:35:08 PM ET
    $ADXN
    $AGYS
    $AIZ
    $ARBK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    EDP Services
    Technology
    Get the next $ADXN alert in real time by email

    Gainers

    • ESSA Pharma Inc. (NASDAQ:EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.
    • Cosmos Holdings Inc. (NASDAQ:COSM) shares jumped 31.7% to $0.1150. Cosmos Holdings CEO Grigorios Siokas bought a total of 12,500,000 shares at an average price of $0.12.
    • Granite Ridge Resources Inc (NASDAQ:GRNT) gained 25.6% to $12.85.
    • Biophytis S.A. (NASDAQ:BPTS) rose 24.6% to $0.6723.
    • TransCode Therapeutics, Inc. (NASDAQ:RNAZ) gained 23.8% to $1.35 after the company reported preclinical results with its lead candidate, TTX-MC138 in Pancreatic Adenocarcinoma.
    • Eqonex Limited (NASDAQ:EQOS) gained 23.5% to $0.420.
    • Cipher Mining Inc. (NASDAQ:CIFR) jumped 22% to $1.01.
    • Nabors Industries Ltd. (NYSE:NBR) rose 21.4% to $166.80 following strong quarterly sales.
    • New Oriental Education & Technology Group Inc. (NYSE:EDU) shares climbed 18.7% to $25.00 after the company reported better-than-expected Q1 EPS and sales results.
    • Helix Energy Solutions Group, Inc. (NYSE:HLX) gained 17.4% to $6.08. BTIG upgraded Helix Energy Solutions from Neutral to Buy and announced a $10 price target.
    • Argo Blockchain plc (NASDAQ:ARBK) rose 17.4% to $2.21 after jumping 36% on Tuesday.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) surged 17.1% to $0.8550.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) gained 16.7% to $1.02. HC Wainwright & Co. initiated coverage on Geovax Labs with a Buy rating and announced a price target of $8.
    • Sintx Technologies, Inc. (NASDAQ:SINT) gained 16.3% to $0.12 after the company announced it was awarded a multi-year DARPA contract to develop CMCs and high temperature coatings for turbine engines.
    • Tenable Holdings, Inc. (NASDAQ:TENB) gained 15.8% to $39.66 following strong Q3 results.
    • ChampionX Corporation (NASDAQ:CHX) gained 15.3% to $28.45 after the company reported Q3 results and announced a $750 million buyback authorization.
    • Agilysys, Inc. (NASDAQ:AGYS) surged 14.6% to $62.90 following better-than-expected Q2 results.
    • Arvinas, Inc. (NASDAQ:ARVN) rose 14.6% to $50.59.
    • Kanzhun Limited (NASDAQ:BZ) gained 14.5% to $12.95.
    • Enphase Energy, Inc. (NASDAQ:ENPH) rose 13.7% to $302.31 after the company reported better-than-expected Q3 adjusted EPS and sales results and issued Q4 revenue guidance above estimates.
    • SharpLink Gaming Ltd. (NASDAQ:SBET) rose 13.2% to $0.77 after gaining around 7% on Tuesday.
    • Hyperfine, Inc. (NASDAQ:HYPR) gained 13.1% to $1.0520.
    • Community Health Systems, Inc. (NYSE:CYH) shares gained 11.6% to $2.3650. The company is set to release quarterly earnings after the closing bell today.
    • Universal Health Services, Inc. (NYSE:UHS) surged 11.6% to $107.88 following strong quarterly results.
    • Femasys Inc. (NASDAQ:FEMY) gained 10.4% to $1.17.
    • Rumble Inc. (NASDAQ:RUM) rose 10% to $9.33 after jumping over 18% on Tuesday.
    • MINISO Group Holding Limited (NASDAQ:MNSO) jumped 9.5% to $5.52.
    • RPC, Inc. (NYSE:RES) gained 8.8% to $10.04 following upbeat earnings.
    • United Maritime Corporation (NASDAQ:USEA) rose 8.4% to $2.70. United Maritime initiated additional $3 million stock buyback plan.


    Losers

    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shares tumbled 47% to $0.1198 after the company priced a public offering of 11,783,572 shares at $0.14 per share.
    • FedNat Holding Company (NASDAQ:FNHC) fell 44% to $0.3398 after the company announced a voluntary Nasdaq delisting.
    • Stride, Inc. (NYSE:LRN) shares dipped 25.8% to $34.51 following weak quarterly earnings.
    • Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO) fell 24.2% to $4.54. Cardio Diagnostics Holdings reported the completion of its business combination with Mana Capital Acquisition Corp.
    • Meiwu Technology Company Limited (NASDAQ:WNW) dropped 21.1% to $1.0099.
    • Sierra Metals Inc. (NYSE:SMTS) fell 20% to $0.1979 after the company reported Q3 production results and announced a voluntary delisting form the NYSe.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) fell 19.6% to $0.3302. Revelation Biosciences recently announced results in a preclinical model of acute and chronic kidney disease. Treatment with REVTx-300 significantly reduced renal cortical fibrosis in a dose dependent manner.
    • Merus N.V. (NASDAQ:MRUS) dropped 17% to $19.63.
    • Tricida, Inc. (NASDAQ:TCDA) fell 16.7% to $0.4601.
    • Taysha Gene Therapies, Inc. (NASDAQ:TSHA) fell 13.6% to $2.5750 after the company announced a $30 million public offering of common stock.
    • CTS Corporation (NYSE:CTS) dropped 12.4% to $38.53 after reporting Q3 results.
    • Constellium SE (NYSE:CSTM) declined 11.3% to $11.45 following Q3 results.
    • Assurant, Inc. (NYSE:AIZ) fell 10% to $137.35 after the company reported preliminary Q3 2022 financial results.
    • Kalera Public Limited Company (NASDAQ:KAL) dropped 9% to $0.1980.
    • Spotify Technology S.A. (NYSE:SPOT) declined 8.2% to $89.12 following Q3 results.
    • Seagate Technology Holdings plc (NASDAQ:STX) fell 7.3% to $53.74 after the company reported worse-than-expected Q1 EPS and sales results and issued Q2 adjusted EPS and sales guidance below estimates.
    • Alphabet Inc. (NASDAQ:GOOG) shares dropped 6.6% to $98.00 after the company reported weaker-than-expected earnings results for its third quarter after the closing bell on Tuesday. YouTube and Network revenue were down on a year-over-year basis, bringing overall Google Ad revenue to $54.48 billion, up from last year’s $53.13 billion.
    • KBR, Inc. (NYSE:KBR) fell 6.4% to $45.87 after the company reported worse-than-expected Q3 sales and narrowed FY22 revenue guidance.
    • Microsoft Corporation (NASDAQ:MSFT) shares fell 5.7% to $236.43. Microsoft posted better-than-expected earnings for its first quarter. Revenue for the Microsoft Cloud segment was $25.7 billion in the first quarter, up 24%% year-over-year.
    • Skechers U.S.A., Inc. (NYSE:SKX) shares fell 4.5% to $34.31 after the company reported weak earnings and issued guidance below analyst estimates.
    Get the next $ADXN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADXN
    $AGYS
    $AIZ
    $ARBK

    CompanyDatePrice TargetRatingAnalyst
    Enphase Energy Inc.
    $ENPH
    2/25/2026$57.00Hold → Buy
    Jefferies
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Spotify Technology S.A.
    $SPOT
    2/11/2026$875.00 → $420.00Buy → Hold
    Pivotal Research Group
    Microsoft Corporation
    $MSFT
    2/9/2026Buy → Hold
    Melius
    Cipher Digital Inc.
    $CIFR
    2/9/2026$38.00Overweight
    Morgan Stanley
    Alphabet Inc.
    $GOOG
    2/5/2026$400.00 → $420.00Buy
    Pivotal Research Group
    Microsoft Corporation
    $MSFT
    2/5/2026$392.00Buy → Hold
    Stifel
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $ADXN
    $AGYS
    $AIZ
    $ARBK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Moyes Jay M bought $2,910 worth of shares (1,000 units at $2.91), increasing direct ownership by 33% to 4,000 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/25/26 9:00:02 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Director Yearwood John bought $500,747 worth of shares (6,410 units at $78.12), increasing direct ownership by 29% to 28,444 units (SEC Form 4)

    4 - NABORS INDUSTRIES LTD (0001163739) (Issuer)

    2/24/26 4:07:58 PM ET
    $NBR
    Oil & Gas Production
    Energy

    Director Anderson Mark Lewis bought $9,060 worth of shares (3,000 units at $3.02), increasing direct ownership by 20% to 18,000 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/19/26 9:00:04 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $ADXN
    $AGYS
    $AIZ
    $ARBK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 6, 2024 - FDA Roundup: December 6, 2024

    For Immediate Release: December 06, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA published the draft guidance, “Expedited Program for Serious Conditions — Accelerated Approval of Drugs and Biologics,” which proposes updates to certain agency policies and procedures regarding accelerated approval. Topics addressed by this

    12/6/24 3:09:02 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AGYS
    $AIZ
    $ARBK
    SEC Filings

    View All

    SEC Form 10-K filed by Constellium SE

    10-K - CONSTELLIUM SE (0001563411) (Filer)

    2/25/26 4:40:38 PM ET
    $CSTM
    Metal Fabrications
    Industrials

    SEC Form SCHEDULE 13G filed by Cipher Mining Inc.

    SCHEDULE 13G - Cipher Digital Inc. (0001819989) (Filed by)

    2/25/26 4:27:32 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    SEC Form 10-K filed by Universal Health Services Inc.

    10-K - UNIVERSAL HEALTH SERVICES INC (0000352915) (Filer)

    2/25/26 4:21:18 PM ET
    $UHS
    Hospital/Nursing Management
    Health Care

    $ADXN
    $AGYS
    $AIZ
    $ARBK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE-MONTH PERIODS ENDED DECEMBER 31, 2025 AND OPERATING RESULTS FORECAST FOR THE FULL YEAR OF 2026

    Consolidated Results of Operations, As Reported and As Adjusted  – Three-month periods ended December 31, 2025 and 2024:KING OF PRUSSIA, Pa., Feb. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $445.9 million, or $7.06 per diluted share, during the fourth quarter of 2025, as compared to $332.4 million, or $4.96 per diluted share, during the fourth quarter of 2024.  Net revenues increased by 9.1% to $4.486 billion during the fourth quarter of 2025, as compared to $4.114 billion during the fourth quarter of 2024. As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"),

    2/25/26 4:16:00 PM ET
    $UHS
    $UHT
    Hospital/Nursing Management
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Sharplink to Host Full Year 2025 Earnings Conference Call and Webcast on March 9, 2026 at 8:30 A.M. E.T.

    MIAMI, FL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sharplink, Inc. (NASDAQ:SBET) ("Sharplink" or the "Company"), one of the world's largest corporate holders of Ether ("ETH") and prominent industry advocate of Ethereum adoption, today announced that the Company will host a conference call on Monday, March 9, 2026 at 8:30 A.M. Eastern Time to discuss its financial and operating results for the full year ended December 31, 2025. The Company will release its financial results in a press release prior to the call. Sharplink's executive team will host the conference call, followed by a question-and-answer period. The conference call details are as follows: Date: Monday, March 9, 2026Time: 8:30 A.M.

    2/25/26 8:00:00 AM ET
    $SBET
    Computer Software: Prepackaged Software
    Technology

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ADXN
    $AGYS
    $AIZ
    $ARBK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Enphase Energy upgraded by Jefferies with a new price target

    Jefferies upgraded Enphase Energy from Hold to Buy and set a new price target of $57.00

    2/25/26 7:19:45 AM ET
    $ENPH
    Semiconductors
    Technology

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Spotify downgraded by Pivotal Research Group with a new price target

    Pivotal Research Group downgraded Spotify from Buy to Hold and set a new price target of $420.00 from $875.00 previously

    2/11/26 9:23:52 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    $ADXN
    $AGYS
    $AIZ
    $ARBK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Loomis David K sold $13,473 worth of shares (1,108 units at $12.16), decreasing direct ownership by 4% to 29,692 units (SEC Form 4)

    4 - ARVINAS, INC. (0001655759) (Issuer)

    2/25/26 5:09:32 PM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Scientific Officer Cacace Angela M sold $43,885 worth of shares (3,609 units at $12.16), decreasing direct ownership by 2% to 147,623 units (SEC Form 4)

    4 - ARVINAS, INC. (0001655759) (Issuer)

    2/25/26 5:09:10 PM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Teel Randy sold $58,198 worth of shares (4,786 units at $12.16), decreasing direct ownership by 3% to 149,696 units (SEC Form 4)

    4 - ARVINAS, INC. (0001655759) (Issuer)

    2/25/26 5:08:46 PM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AGYS
    $AIZ
    $ARBK
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Sharplink Announces Record 46% Institutional Ownership, Brand Refresh and Expansion of Leadership Team

    MIAMI, FL, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Sharplink, Inc. (NASDAQ:SBET) ("Sharplink" or the "Company"), one of the world's largest corporate holders of Ether ("ETH") and prominent industry advocate of Ethereum adoption, today announced record level institutional ownership of its common stock. According to the latest available Form 13F filings, institutional ownership of Sharplink's common stock has grown to 46% as of December 31, 2025. The Company's institutional investor base is now one of the largest among all Ethereum-focused digital asset treasury ("DAT") companies. Joseph Chalom, CEO of Sharplink, stated, "This record level of institutional ownership confirms that sophisticated i

    2/19/26 8:00:00 AM ET
    $SBET
    Computer Software: Prepackaged Software
    Technology

    SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

    Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on silicon nitride (SiN) solutions for medical and other high-value applications, today announced the appointment of Ryan Elmore as President of SINTX Technologies, Inc., effective March 16, 2026. Mr. Elmore most recently served as Core Business Director at Invibio, a division of Victrex plc. With more than 15 years of experience in advanced biomaterials and medical dev

    2/18/26 8:30:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $ADXN
    $AGYS
    $AIZ
    $ARBK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Assurant Inc.

    SC 13G/A - ASSURANT, INC. (0001267238) (Subject)

    12/9/24 6:04:05 AM ET
    $AIZ
    Property-Casualty Insurers
    Finance

    Amendment: SEC Form SC 13D/A filed by United Maritime Corporation

    SC 13D/A - United Maritime Corp (0001912847) (Subject)

    11/26/24 4:05:48 PM ET
    $USEA
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by ESSA Pharma Inc.

    SC 13G/A - ESSA Pharma Inc. (0001633932) (Subject)

    11/14/24 7:32:27 PM ET
    $EPIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AGYS
    $AIZ
    $ARBK
    Financials

    Live finance-specific insights

    View All

    UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE-MONTH PERIODS ENDED DECEMBER 31, 2025 AND OPERATING RESULTS FORECAST FOR THE FULL YEAR OF 2026

    Consolidated Results of Operations, As Reported and As Adjusted  – Three-month periods ended December 31, 2025 and 2024:KING OF PRUSSIA, Pa., Feb. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $445.9 million, or $7.06 per diluted share, during the fourth quarter of 2025, as compared to $332.4 million, or $4.96 per diluted share, during the fourth quarter of 2024.  Net revenues increased by 9.1% to $4.486 billion during the fourth quarter of 2025, as compared to $4.114 billion during the fourth quarter of 2024. As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"),

    2/25/26 4:16:00 PM ET
    $UHS
    $UHT
    Hospital/Nursing Management
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Sharplink to Host Full Year 2025 Earnings Conference Call and Webcast on March 9, 2026 at 8:30 A.M. E.T.

    MIAMI, FL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sharplink, Inc. (NASDAQ:SBET) ("Sharplink" or the "Company"), one of the world's largest corporate holders of Ether ("ETH") and prominent industry advocate of Ethereum adoption, today announced that the Company will host a conference call on Monday, March 9, 2026 at 8:30 A.M. Eastern Time to discuss its financial and operating results for the full year ended December 31, 2025. The Company will release its financial results in a press release prior to the call. Sharplink's executive team will host the conference call, followed by a question-and-answer period. The conference call details are as follows: Date: Monday, March 9, 2026Time: 8:30 A.M.

    2/25/26 8:00:00 AM ET
    $SBET
    Computer Software: Prepackaged Software
    Technology

    Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

    – Company entering 2026 with the potential to deliver multiple value-driving milestones, including data readouts from ARV-102, ARV-806, and ARV-393, with cash runway into second half of 2028 – – ARV-102 (LRRK2) Phase 1 clinical data in patients with Parkinson's disease accepted for oral presentation at AP/PD Conference in March 2026 – – Clinical data from ARV-806 (KRAS G12D) and ARV-393 (BCL6) on track for presentations in 2026 – – Phase 1 trial in healthy volunteers initiated with polyQ-AR degrader ARV-027; first immuno-oncology PROTAC HPK1 degrader, ARV-6723, on track to initiate Phase 1 trial in mid-2026 – – Randy Teel, Ph.D., appointed President, Chief Executive Officer, and

    2/24/26 7:00:00 AM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care